Antiretroviral treatment in human immunodeficiency virus infection
Blum, L.; Bachmeyer, C.
Annales de Dermatologie et de Venereologie 124(9): 641-654
1997
ISSN/ISBN: 0151-9638 PMID: 9739932 Document Number: 472771
Document emailed within 1 workday
Related Documents
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Dormont, J.; Aboulker, J.P. 1994: Antiretroviral treatments in human immunodeficiency virus infection La Revue du Praticien 44(12): 1635-1642
Emery, S.; Cooper, D.A. 1995: Antiretroviral therapy of human immunodeficiency virus type-1 (HIV-1) infection Australian and New Zealand Journal of Medicine 25(4): 344-349
Stephens, J.R.; Rathbun, R.C.; Lockhart, S.M.; Bronze, M.S.; Greenfield, R.A. 2007: Part XV. Antiretroviral therapy for human immunodeficiency virus infection Journal of the Oklahoma State Medical Association 100(11): 417-424
Roux, P.; Fugon, L.; Winnock, M.; Salmon-Céron, D.; Lacombe, K.; Sogni, P.; Spire, B.; Dabis, F.ço.; Carrieri, M.P. 2012: Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users Addiction 107(1): 152-159
Bearden, D.; Steenhoff, A.P.; Dlugos, D.J.; Kolson, D.; Mehta, P.; Kessler, S.; Lowenthal, E.; Monokwane, B.; Anabwani, G.; Bisson, G.P. 2015: Early antiretroviral therapy is protective against epilepsy in children with human immunodeficiency virus infection in botswana Journal of Acquired Immune Deficiency Syndromes 69(2): 193-199
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
Anabwani, G.M.; Woldetsadik, E.A.; Kline, M.W. 2005: Treatment of human immunodeficiency virus (HIV) in children using antiretroviral drugs Seminars in Pediatric Infectious Diseases 16(2): 116-124
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Lin, W.-C.; Lin, H.-H.; Lee, S.S.-J.; Sy, C.-L.; Wu, K.-S.; Chen, J.-K.; Tsai, H.-C.; Chen, Y.-S. 2016: Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country Journal of Microbiology Immunology and Infection 49(5): 729-736
Lynch, M.L.; DeGruttola, V. 2015: Predicting time to threshold for initiating antiretroviral treatment to evaluate cost of treatment as prevention of human immunodeficiency virus Journal of the Royal Statistical Society. Series C Applied Statistics 64(2): 359-375
Guevara-Silva, E.A. 2014: Cognitive impairment and antiretroviral treatment in a Peruvian population of patients with human immunodeficiency virus Neurologia 29(4): 224-229
Segat, L.; Crovella, S. 2012: HLA-G 14bp del/ins genetic variation: association with susceptibility to human immunodeficiency virus-1 vertical transmission but not with human immunodeficiency virus-1 infection through horizontal transmission Tissue Antigens 80(1): 12-13
Wen, Y.; Guan, J.; Wu, Z.; Li, L.; Rotheram-Borus, M.Jane.; Lin, C.; Detels, R. 2009: Pharmacy workers' sexually transmitted diseases/human immunodeficiency virus knowledge in Fuzhou, China: implications for human immunodeficiency virus testing, treatment, and prevention strategies Sexually Transmitted Diseases 36(4): 221-226
Ebonyi, A.O.; Ejeliogu, E.U.; Okpe, S.E.; Shwe, D.D.; Yiltok, E.S.; Ochoga, M.O.; Oguche, S. 2015: Factors associated with antiretroviral treatment interruption in human immunodeficiency virus (HIV)-1-infected children attending the Jos University Teaching Hospital, Jos, Nigeria Nigerian Medical Journal: Journal of the Nigeria Medical Association 56(1): 43-47
Frantz, J.M.; Murenzi, A. 2013: The physical activity levels among people living with human immunodeficiency virus/acquired immunodeficiency syndrome receiving high active antiretroviral therapy in Rwanda Sahara J: Journal of Social Aspects of Hiv/Aids Research Alliance 10(3-4): 113-118
Johnson, L.F.; Hallett, T.B.; Rehle, T.M.; Dorrington, R.E. 2012: The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis Journal of the Royal Society Interface 9(72): 1544-1554
Henry, D.H.; Beall, G.N.; Benson, C.A.; Carey, J.; Cone, L.A.; Eron, L.J.; Fiala, M.; Fischl, M.A.; Gabin, S.J.; Gottlieb, M.S. 1992: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials Annals of Internal Medicine 117(9): 739-748